T 1317/15 (Recombinantly produced human factor VIII/OCTAPHARMA) of 19.06.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T131715.20190619
- Date of decision
- 19 June 2019
- Case number
- T 1317/15
- Petition for review of
- -
- Application number
- 09782080.7
- IPC class
- C07K 14/755C07K 14/745A61K 38/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Recombinantly produced human factor VIII and IX
- Applicant name
- Octapharma AG
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Main request: novelty (no);
Auxiliary requests 1 to 7: could have been filed in first instance proceedings (yes), admitted (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.